Skip to Main Content

Paper Details

Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding.
J Hypertens
39
2021
ACE, COVID-19, angiotensin II, angiotensin II receptor, angiotensin-converting enzyme, collider, hypertension, patient, renin--angiotensin
Author NameAffiliation
Lucy D'Agostino McGowanWake Forest University.
Andrew M South
Andrew M SouthBrenner Children's Hospital.
Andrew M South
Andrew M SouthWake Forest School of Medicine
Andrew M South
Andrew M SouthBrenner Children's Hospital.
Andrew M South
Andrew M SouthWake Forest School of Medicine
  • 1 - 9

Datasets

Release 1.2